[Allergy and leukotrienes].
作者信息
Ado V A, Mokronosova M A, Perlamutrov Iu N
出版信息
Klin Med (Mosk). 1995;73(2):9-12.
PMID:7609435
Abstract
摘要
相似文献
1
[Allergy and leukotrienes].
Klin Med (Mosk). 1995;73(2):9-12.
2
Asthma therapy with agents preventing leukotriene synthesis or action.使用预防白三烯合成或作用的药物进行哮喘治疗。
Proc Assoc Am Physicians. 1999 Nov-Dec;111(6):547-59. doi: 10.1046/j.1525-1381.1999.t01-1-99242.x.
3
Zileuton: clinical implications of 5-Lipoxygenase inhibition in severe airway disease.齐留通：5-脂氧合酶抑制在严重气道疾病中的临床意义
Int J Clin Pract. 2007 Apr;61(4):663-76. doi: 10.1111/j.1742-1241.2007.01320.x.
4
New directions in asthma drug therapy.
Hosp Pract (1995). 1998 Feb 15;33(2):25-6, 31-3, 36-8. doi: 10.1080/21548331.1998.11443632.
5
The role of leukotriene modifiers in the treatment of asthma.白三烯调节剂在哮喘治疗中的作用。
Am J Respir Crit Care Med. 1998 May;157(5 Pt 1):1363-71. doi: 10.1164/ajrccm.157.5.9706059.
6
[5-lipoxygenase inhibitors in asthma therapy].
Nihon Rinsho. 1996 Nov;54(11):3040-4.
7
Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma.新型 5-脂氧合酶抑制剂治疗哮喘的研究进展。
Eur J Med Chem. 2018 Jun 10;153:65-72. doi: 10.1016/j.ejmech.2017.10.020. Epub 2017 Oct 10.
8
Identification of 4-[4-(4-fluoro-phenyl)-thiazol-2-ylamino]-2,6-dimethyl-phenol (KR-33749) as an inhibitor of 5-lipoxygenase with potent antiinflammatory activity.鉴定出 4-[4-(4-氟苯基)-噻唑-2-基氨基]-2,6-二甲基苯酚（KR-33749）是一种具有强效抗炎活性的 5-脂氧合酶抑制剂。
Pharmacology. 2010;86(2):65-72. doi: 10.1159/000315488. Epub 2010 Jul 17.
9
Leukotrienes in asthma. The potential therapeutic role of antileukotriene agents.哮喘中的白三烯。抗白三烯药物的潜在治疗作用。
Arch Intern Med. 1996 Oct 28;156(19):2181-9. doi: 10.1001/archinte.156.19.2181.
10
Treatment of asthma with drugs modifying the leukotriene pathway.使用改变白三烯途径的药物治疗哮喘。
N Engl J Med. 1999 Jan 21;340(3):197-206. doi: 10.1056/NEJM199901213400306.
Zotero 插件